Interleukin-6 and interleukin-12 participate in induction of a type 1 protective T-cell response during vaccination with a tuberculosis subunit vaccine

被引:98
作者
Leal, IS
Smedegård, B
Andersen, P
Appelberg, R
机构
[1] Univ Porto, Inst Mol & Cell Biol, Lab Microbiol & Immunol Infect, P-4150 Porto, Portugal
[2] Statens Serum Inst, Dept TB Immunol, DK-2300 Copenhagen, Denmark
关键词
D O I
10.1128/IAI.67.11.5747-5754.1999
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We examined the role of cytokines in the development of gamma interferon (IFN-gamma)-secreting protective T cells following immunization with a culture filtrate subunit vaccine against Mycobacterium tuberculosis containing the adjuvant dimethyldioctadecylammonium bromide (DDA). Depletion of either interleukin-6 (IL-6) or IL-12 with specific neutralizing antibodies during vaccination reduced the priming of T cells for antigen-Specific proliferation and IFN-gamma secretion. Such reduction was also observed in IL-6 gene-disrupted mice as compared to wild-type animals. IL-6 was found to play a role in the initial differentiation of Th1 cells but not in their expansion. The defect found after IL-6 depletion or in IL-6-knockout mice was compensated by the inclusion of recombinant mouse IL-12 in the vaccine. The induction of protective immunity against an intravenous or an aerosol challenge with live, virulent M. tuberculosis was markedly reduced by neutralizing either IL-6 or IL-12 during immunization with the vaccine. Likewise, the effects of IL-6 neutralization were partially reversed by including IL-12 in the vaccine. Our data point to an important role of IL-6 and IL-12 in the generation of cell-mediated immunity to tuberculosis.
引用
收藏
页码:5747 / 5754
页数:8
相关论文
共 53 条
[1]   T-CELL PROLIFERATIVE RESPONSE TO ANTIGENS SECRETED BY MYCOBACTERIUM-TUBERCULOSIS [J].
ANDERSEN, P ;
ASKGAARD, D ;
LJUNGQVIST, L ;
BENTZON, MW ;
HERON, I .
INFECTION AND IMMUNITY, 1991, 59 (04) :1558-1563
[2]   Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis [J].
Andersen, P .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1997, 45 (02) :115-131
[4]   PROTEINS RELEASED FROM MYCOBACTERIUM-TUBERCULOSIS DURING GROWTH [J].
ANDERSEN, P ;
ASKGAARD, D ;
LJUNGQVIST, L ;
BENNEDSEN, J ;
HERON, I .
INFECTION AND IMMUNITY, 1991, 59 (06) :1905-1910
[5]  
APPELBERG R, 1994, IMMUNOLOGY, V82, P361
[6]   Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis [J].
Baldwin, SL ;
D'Souza, C ;
Roberts, AD ;
Kelly, BP ;
Frank, AA ;
Lui, MA ;
Ulmer, JB ;
Huygen, K ;
McMurray, DM ;
Orme, IM .
INFECTION AND IMMUNITY, 1998, 66 (06) :2951-2959
[7]   INTERLEUKIN-6 ANTAGONIZES TUMOR NECROSIS FACTOR-MEDIATED MYCOBACTERIOSTATIC AND MYCOBACTERIOCIDAL ACTIVITIES IN MACROPHAGES [J].
BERMUDEZ, LE ;
WU, M ;
PETROFSKY, M ;
YOUNG, LS .
INFECTION AND IMMUNITY, 1992, 60 (10) :4245-4252
[8]   Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line [J].
Biswas, P ;
Delfanti, F ;
Bernasconi, S ;
Mengozzi, M ;
Cota, M ;
Polentarutti, N ;
Mantovani, A ;
Lazzarin, A ;
Sozzani, S ;
Poli, G .
BLOOD, 1998, 91 (01) :258-265
[9]  
Brandt L, 1996, J IMMUNOL, V157, P3527
[10]   DISSEMINATED TUBERCULOSIS IN INTERFERON-GAMMA GENE-DISRUPTED MICE [J].
COOPER, AM ;
DALTON, DK ;
STEWART, TA ;
GRIFFIN, JP ;
RUSSELL, DG ;
ORME, IM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2243-2247